Abstract
The long pentraxin 3 (PTX3), described initially as a microvascular inflammation marker, is an acute-phase protein released by several cell types in response to infection or tissue damage. It contributes to resistance to bacteria, fungi, viruses, and inflammation regulation (1). Circulating PTX3 was abnormally high (>2 ng/ml) in all 958 patients with severe sepsis or septic shock included in a pre-planned sub-study of the Albumin Italian Outcome Sepsis (ALBIOS) trial (2).
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call